NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWAN

Author： Lin Pinpin Wang Hsiu-Jen Lee Huei Lee Hong-Shen Wang Shu-Li Hsueh Yu-Mei Tsai Kan-Jen Chen Chih-Yi

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.58, Iss.4, 1999-10, pp. : 187-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)

Current Pharmacogenomics, Vol. 2, Iss. 1, 2004-03 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of Heme Oxygenase-1 (HO-1) and NAD[P]H: Quinone Oxidoreductase 1 (NQO1) by a Phenolic Antioxidant, Butylated Hydroxyanisole (BHA) and Its Metabolite, tert-Butylhydroquinone (tBHQ) in Primary-Cultured Human and Rat Hepatocytes

By Keum Young-Sam Han Yong-Hae Liew Celine Kim Jung-Hwan Xu Changjiang Yuan Xiaoling Shakarjian Michael Chong Saeho Kong Ah-Ng

Pharmaceutical Research, Vol. 23, Iss. 11, 2006-11 ,pp. : 2586-2594

Springer Publishing Company

Access to resources Recommend Favorite

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

By Cai H. Griendling K.K. Harrison D.G.

Trends in Pharmacological Sciences, Vol. 24, Iss. 9, 2003-09 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite

The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase

By Laplante Marc-André de Champlain Jacques

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 21-28

NRC Research Press

Access to resources Recommend Favorite

Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

Current Drug Metabolism, Vol. 9, Iss. 8, 2008-01 ,pp. : 686-696

Bentham Science Publishers

Access to resources Recommend Favorite